Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Ransi Somaratne
Based on 14 articles published since 2008
||||
Expertise Level
The expertise of Ransi Somaratne ranks in the
  • Top 0.14%
  • ... of 28,550 published authors worldwide on Hypercholesterolemia
  • ... from 2008 through 2018
  • ... based on contributions to 14 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Miscellaneous institutions in Thousand Oaks      
2017
  • Amgen Inc, Thousand Oaks, CA, USA. · Current affiliation: AbbVie, North Chicago, IL, USA. · Current affiliation: BioMarin Pharmaceuticals, Novato, CA, USA. · Current affiliation: Quantitative Solutions, a Certara Company, Seattle, WA, USA. · Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town,  South Africa. · Pubmed 27861991
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: · Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo, Norway. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Molecular Medicine, University of Pavia and Cardiac Intensive Care Unit and Laboratories for Experimental Cardiology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy. · Department of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of Warsaw, Warsaw, Poland. · Center of Preventive Cardiology, 3rd Department Internal Medicine, University General Hospital and 1st Medical Faculty, Prague, Czech Republic. · 1st Department of Medicine, University of Pécs, Pécs, Hungary. · Polyclinic for Endocrinology, Diabetes, and Preventive Medicine, University of Cologne, Cologne, Germany. · Lipids and Atherosclerosis Unit, Maimonides Biomedical Research Institute of Cordoba, Reina Sofia University Hospital, University of Cordoba, CIBEROBN, Cordoba, Spain. · University Hospital Center Besançon, Besançon, France. · Hopital Cantonal, Hopitaux Universitaires de Geneva, Geneva, Switzerland. · Rhode Island Hospital, Department of Neurology, Alpert Medical School of Brown University, Providence, RI, USA. · Amgen, Thousand Oaks, CA, USA. · Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia. · International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK. · Pubmed 28859947
  • Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. Electronic address: · CGH Medical Center, Sterling, Illinois; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Division of Lipidology, Department of Medicine, University of Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Cardiovascular Research Group, School of Biomedicine, University of Manchester, Manchester, UK. · Amgen Inc., Thousand Oaks, California. · Amgen Ltd., Cambridge, UK. · MRC Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: · Pubmed 28844508
2016
  • Amgen Inc., Thousand Oaks, CA. · Amgen Ltd., Uxbridge, United Kingdom. · Pubmed 27707817
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
2014
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City. · Center for Clinical and Basic Research, Aalborg, Denmark. · Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham. · Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami. · Orange County Research Center, Tustin, California. · Hampton Roads Center for Clinical Research, Suffolk, Virginia. · Amgen Inc, Thousand Oaks, California. · Maine Research Associates, Auburn. · Pubmed 24825642
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.) · Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.) · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.) · Bethesda Health Research Center, Bethesda, MD (M.B.) · Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.) · Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.) · and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
2015
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.) · the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa · the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.) · the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.) · Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott) · Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 14 total) written by Ransi Somaratne about Hypercholesterolemia:

  • Impact of Target-Mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9). 2017
  • Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial. 2017
  • Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus. 2017
  • Effect of evolocumab on cholesterol synthesis and absorption. 2016
  • Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. 2016
  • Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. 2015
  • Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial. 2014
  • Rationale and design of LAPLACE-2: a phase 3, randomized, double-blind, placebo- and ezetimibe-controlled trial evaluating the efficacy and safety of evolocumab in subjects with hypercholesterolemia on background statin therapy. 2014
  • AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57). 2014
  • Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. 2014
Show List of Full Article Records
Google Searches

Learn more about Ransi Somaratne using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Thousand Oaks
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Thousand Oaks
2017
  • Amgen Inc, Thousand Oaks, CA, USA. · Current affiliation: AbbVie, North Chicago, IL, USA. · Current affiliation: BioMarin Pharmaceuticals, Novato, CA, USA. · Current affiliation: Quantitative Solutions, a Certara Company, Seattle, WA, USA. · Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town,  South Africa. · Pubmed 27861991
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: · Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo, Norway. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Molecular Medicine, University of Pavia and Cardiac Intensive Care Unit and Laboratories for Experimental Cardiology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy. · Department of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of Warsaw, Warsaw, Poland. · Center of Preventive Cardiology, 3rd Department Internal Medicine, University General Hospital and 1st Medical Faculty, Prague, Czech Republic. · 1st Department of Medicine, University of Pécs, Pécs, Hungary. · Polyclinic for Endocrinology, Diabetes, and Preventive Medicine, University of Cologne, Cologne, Germany. · Lipids and Atherosclerosis Unit, Maimonides Biomedical Research Institute of Cordoba, Reina Sofia University Hospital, University of Cordoba, CIBEROBN, Cordoba, Spain. · University Hospital Center Besançon, Besançon, France. · Hopital Cantonal, Hopitaux Universitaires de Geneva, Geneva, Switzerland. · Rhode Island Hospital, Department of Neurology, Alpert Medical School of Brown University, Providence, RI, USA. · Amgen, Thousand Oaks, CA, USA. · Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia. · International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK. · Pubmed 28859947
  • Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. Electronic address: · CGH Medical Center, Sterling, Illinois; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Division of Lipidology, Department of Medicine, University of Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Cardiovascular Research Group, School of Biomedicine, University of Manchester, Manchester, UK. · Amgen Inc., Thousand Oaks, California. · Amgen Ltd., Cambridge, UK. · MRC Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: · Pubmed 28844508
2016
  • Amgen Inc., Thousand Oaks, CA. · Amgen Ltd., Uxbridge, United Kingdom. · Pubmed 27707817
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
2014
  • Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City. · Center for Clinical and Basic Research, Aalborg, Denmark. · Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham. · Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami. · Orange County Research Center, Tustin, California. · Hampton Roads Center for Clinical Research, Suffolk, Virginia. · Amgen Inc, Thousand Oaks, California. · Maine Research Associates, Auburn. · Pubmed 24825642
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.) · Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.) · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.) · Bethesda Health Research Center, Bethesda, MD (M.B.) · Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.) · Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.) · and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
2015
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.) · the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa · the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.) · the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.) · Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott) · Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
8 Other Locations Show
Yearly article counts 03214220000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.